Mail-Order Mifepristone Effective, Feasible for Medication Abortion
By Elana Gotkine HealthDay Reporter
MONDAY, May 13, 2024 -- Mail-order pharmacy dispensing of mifepristone for medication abortion is effective, acceptable, and feasible, according to a study published online May 13 in JAMA Internal Medicine.
Daniel Grossman, M.D., from the University of California, San Francisco, and colleagues estimated the effectiveness, acceptability, and feasibility of dispensing mifepristone for medication abortion using a mail-order pharmacy in a prospective cohort study including 11 clinics in seven states. Eligible participants were seeking medication abortion at 63 or fewer days of gestation. After in-person screening assessing eligibility for medication abortion, mifepristone and misoprostol were prescribed using a mail-order pharmacy.
Clinical outcome information was obtained and analyzed from 510 abortions among 506 participants. Medications were received within three days for 436 (85.5 percent) of these abortions. In 499 cases (97.8 percent), complete abortion occurred after medication use. The researchers found that 24 adverse events (4.7 percent) occurred for which care was sought for medication abortion symptoms; serious adverse events requiring hospitalization were experienced by three patients (0.6 percent), but no adverse events were associated with mail-order dispensing. Overall, 90.4 percent of 477 participants indicated that they would use mail-order dispensing again for abortion care and 91.2 percent reported satisfaction with medication abortion. Findings were similar to those of studies reporting in-person dispensing.
"This study adds to the substantial body of evidence supporting the U.S. Food and Drug Administration's decision to remove the in-person dispensing requirement for mifepristone," the authors write.
One author served as an expert witness in cases challenging abortion restrictions, including restrictions on telemedicine.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Considerable Number of Abortion Seekers Accessed Services After Dobbs
MONDAY, March 25, 2024 -- Despite implementation of state-level bans and restrictions on abortion after the Supreme Court decision in Dobbs v. Jackson Women's Health Organization...
2020 to 2021 Saw Nonsignificant Decline in Perinatal Mortality Rate
THURSDAY, Dec. 7, 2023 -- A nonsignificant decline was seen in the U.S. perinatal mortality rate from 2020 to 2021, according to a December data brief published by the U.S...
CDC: 2020 to 2021 Saw Rise in Total Number, Rate, Ratio of Abortions
WEDNESDAY, Nov. 22, 2023 -- From 2020 to 2021, there were increases in the total number, rate, and ratio of reported abortions, according to research published in the Nov. 24...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.